(Q39735956)

14 September 2017

Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration. (English)

1 reference

14 September 2017

1 reference

Flavio Curnis

1

1 reference

14 September 2017

Angelina Sacchi

series ordinal

2

1 reference

14 September 2017

Angelo Corti

series ordinal

3

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Journal of Clinical Investigation

14 September 2017

1 reference

14 September 2017

110

1 reference

14 September 2017

4

1 reference

14 September 2017

475-482

1 reference

Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150417

TNF-alpha augments intratumoural concentrations of doxorubicin in TNF-alpha-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150417

Upregulation of p75 tumor necrosis factor alpha receptor in Mycobacterium avium-infected mice: evidence for a functional role.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150417

Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150417

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150417

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150417

Reduction of interstitial fluid pressure after TNF-alpha treatment of three human melanoma xenografts

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150417

Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150417

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150417

The two different receptors for tumor necrosis factor mediate distinct cellular responses

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150417

Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13).

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150417

Tumor necrosis factor-alpha augments pulmonary arterial transendothelial albumin flux in vitro

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=150417

Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study

17 June 2018

1 reference

12 December 2020

Tumor cell targeting with antibody-avidin complexes and biotinylated tumor necrosis factor alpha

1 reference

12 December 2020

Tumour necrosis factor: strategies for improving the therapeutic index

1 reference

12 December 2020

Tumor pretargeting with avidin improves the therapeutic index of biotinylated tumor necrosis factor alpha in mouse models

1 reference

12 December 2020

Soft tissue limb sarcomas: Italian clinical trials with hyperthermic antiblastic perfusion

1 reference

12 December 2020

Caspase inhibition reveals functional cooperation between p55- and p75-TNF receptors in cell necrosis

1 reference

12 December 2020

Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells

1 reference

12 December 2020

The active form of tumor necrosis factor is a trimer

1 reference

12 December 2020

Flow cytometric analysis of doxorubicin accumulation in cells from human and rodent cell lines

1 reference

12 December 2020

Augmentation for intratumoral accumulation and anti-tumor activity of liposome-encapsulated adriamycin by tumor necrosis factor-alpha in mice

1 reference

12 December 2020

Barriers to drug delivery in solid tumors

1 reference

12 December 2020

Tumor Necrosis Factor (TNF) α quantification by ELISA and bioassay: effects of TNFα-soluble TNF receptor (p55) complex dissociation during assay incubations

1 reference

12 December 2020

High dose recombinant tumour necrosis factor (rTNF alpha) administered by isolation perfusion for advanced tumours of the limbs: a model for biochemotherapy of cancer

1 reference

12 December 2020

Phase I study of tumor necrosis factor plus actinomycin D in patients with androgen-independent prostate cancer

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI0215223

1 reference

14 September 2017

1 reference

14 September 2017

PubMed publication ID

12189241

1 reference